| 1. |
- Wang, Zheng, et al.
(author)
-
Trade-off effect of hydrogen-bonded dopant-free hole transport materials on performance of inverted perovskite solar cells
- 2024
-
In: Nano Energy. - 2211-2855. ; 128
-
Journal article (peer-reviewed)abstract
- Benefiting from their ordered orientation and superior stability compared to traditional conjugated materials, hydrogen bonding (HB)-induced H-aggregates in organic small molecule hole-transport materials (HTMs) hold a big potential for high-performance inverted perovskite solar cells (IPSCs). However, H-aggregates can also lead to excessive face-aggregation by forming the gaps between aggregates, which is in turn unfavorable for charge mobility and thus for the overall device performance. Herein, we design and synthesize a new set of HB-containing triphenylamine-based small molecules to tailor the degree of H-aggregation, namely O1 (without HB), O2 (unilateral HB unit), and O3 (bilateral HB units). These HTMs make a clear trade-off effect on the charge mobility within the HTM and the interfacial properties of perovskite and HTM. Although the interfacial hole extraction process is promoted upon the HB-functionalized interface, the best performance of IPSCs is still achieved by O1 HTM, which is mainly influenced by the higher hole mobility without HB-induced H-aggregates. Nevertheless, the photo stability of as-fabricated devices is effectively improved upon the HB passivation effect on the interface of HTM (O2 or O3) and perovskite, as well as the better quality of atop perovskite layers with less grain boundary compared to the reference case (O1).
|
|
| 2. |
- Li, Yifei, et al.
(author)
-
Can Nup88 expression be associated with atypical endometrial hyperplasia and endometrial cancer? A preliminary study
- 2016
-
In: Pathology, Research and Practice. - : ELSEVIER GMBH, URBAN & FISCHER VERLAG. - 0344-0338 .- 1618-0631. ; 212:4, s. 274-278
-
Journal article (peer-reviewed)abstract
- Background: Nup88 is overexpressed in a number of types of carcinomas and is associated with myometrial invasion, but its exact expression pattern in endometrial cancer and premalignant lesions is unknown. Aims: To evaluate the role of Nup88 in endometrial cancers and atypical endometrial hyperplasia and its clinicopathological significance. Methods: Nup88 expression was examined by immunohistochemistry in samples from 104 endometrial cancers, 21 atypical endometrial hyperplasia lesions, and 40 normal endometria. All samples were from patients who underwent surgery at the First Hospital of Hebei Medical University (Shijiazhuang, China) between April 2006 and December 2009. Nup88 expression was compared between the groups and associations were assessed between Nup88 and clinicopathological characteristics of the subjects. Results: Nup88 expression in cancer (76% of samples) and atypical hyperplasia (91%) was significantly higher compared to normal endometrium (33%, both P < 0.001), but there was no significant difference between endometrial cancer and atypical hyperplasia (P = 0.237). The expression of Nup88 increased significantly with increasing exposure time to estrogen (P = 0.033). Conclusions: Nup88 may be related to the occurrence of endometrial cancers and premalignant lesions. Nup88 might be a useful biomarker for pre-malignant lesions and early-stage endometrial cancer. (C) 2016 Elsevier GmbH. All rights reserved.
|
|
| 3. |
- Li, Yifei, et al.
(author)
-
Expression and clinical significance of FXYD3 in endometrial cancer
- 2014
-
In: Oncology Letters. - : Spandidos Publications. - 1792-1074 .- 1792-1082. ; 8:2, s. 517-522
-
Journal article (peer-reviewed)abstract
- FXYD3 expression is upregulated in numerous cancer cell types. The present study compared the FXDY3 expression in normal endometrium, premalignant lesion and endometrial cancer tissue samples, and investigated the correlation between FXDY3 expression and clinicopathological features. FXYD3 expression was analyzed by streptavidin-peroxidase immunohistochemistry in 21 normal endometrial tissue samples, 18 atypical endometrial hyperplasia samples and 50 tissues obtained from patients diagnosed with endometrial cancer. The percentage of FXYD3-positive cell expression in the normal endometrium, atypical hyperplasia and endometrial cancer tissues samples was 0, 22, and 26%, respectively. The differences between the atypical hyperplasia and endometrial cancer groups were statistically significant when compared with the normal group (P=0.007 and P=0.037, respectively). There was no significant difference between the atypical hyperplasia and endometrial cancer groups. The percentage of FXYD3-positive cells correlated with the fertility frequency (Pless than0.05). In conclusion, FXYD3 is a potential biomarker for endometrial cancer, and its upregulation may be an early event in endometrial carcinoma progression. In addition, FXYD3 expression in endometrial carcinoma correlates with fertility frequency.
|
|
| 4. |
- Li, Rui, et al.
(author)
-
Twisted or Planar? Side-Chain Tailoring of Fluorene-based Hole-Transport Materials for Efficient and Stable Perovskite Solar Cells
- 2023
-
In: Solar RRL. - 2367-198X. ; 7:18
-
Journal article (peer-reviewed)abstract
- The functionalization of small-molecule hole-transport materials (HTMs) heavily relies on the rational design of molecular geometry, which can optimize both intrinsic HTM properties and interfacial properties for realizing high-performance and stable lead halide perovskite solar cells (LHPSCs). Herein, two fluorene-based donor–π linker–donor HTMs are seen, FL01 and FL02, whose side chains are tailored with planar phenyl-carbazole groups and twisted triphenylamine groups, respectively. Benefiting from the high conformational flexibility of twisted side chains, the strong and oriented interaction via PbO bonding is well coordinated at the perovskite and FL02 interface, which favors the interfacial charge transfer as well as the protection of perovskite layer by effectively blocking or mitigating the diffusion of hygroscopic dopants toward the perovskite surface. Consequently, the performance of FL02 HTM-based n–i–p LHPSCs is significantly enhanced by achieving a power conversion efficiency of 17.8%, which is twice higher than that (8.6%) of FL01 HTM-based ones and comparable with the case (18.8%) of conventional spiro-OMeTAD HTM-based devices. More importantly, the FL02-based devices exhibit impressively high operation and storage stabilities with T80 and TS80 lifetimes of >98 h and ≈270 days, respectively, which are among the longest lifespans for the type of hygroscopically doped LHPSCs.
|
|
